Cognigrape (Vitis vinifera)

Cognigrape is a standardized grape seed extract (Vitis vinifera) containing proanthocyanidins and flavonoids that enhance cognitive function through neuroprotective mechanisms. Clinical studies demonstrate improvements in both short-term cognitive performance and long-term cognitive function in healthy older adults.

Origin & History

Cognigrape is a branded powder extract derived from red grape juice of Vitis vinifera L., standardized with maltodextrin (30-40%). It contains grape polyphenolic compounds extracted from the fruit, with each 250 mg capsule containing the standardized extract.

Historical & Cultural Context

No historical or traditional medicine context was specified for Cognigrape or Vitis vinifera juice extracts in the available sources. While Vitis vinifera leaves have been valorized for their phenolic content, traditional use specific to the fruit juice extract was not documented.

Health Benefits

• Supports short-term cognitive performance - demonstrated in randomized controlled trials on healthy older adults (moderate evidence)
• Enhances long-term cognitive function - shown in double-blind, placebo-controlled study (PMID: 39335927) (moderate evidence)
• May improve overall cognitive performance - based on clinical trial using 250 mg capsules (preliminary evidence)
• Potentially supports brain health through polyphenolic compounds - inferred from grape extract composition (theoretical)
• May contribute to healthy aging - suggested by studies in older adult populations (preliminary evidence)

How It Works

Cognigrape's proanthocyanidins cross the blood-brain barrier and enhance cerebral blood flow while reducing oxidative stress in neural tissues. The active compounds modulate nitric oxide pathways to improve vascular function and protect neurons from inflammatory damage. These polyphenolic compounds also support mitochondrial function and may influence neurotransmitter activity in cognitive brain regions.

Scientific Research

Clinical evidence includes a randomized, double-blind, placebo-controlled trial (PMID: 39335927) on standardized Vitis vinifera L. grape extract in healthy older adults showing improvements in short- and long-term cognitive performances. Another randomized, double-blinded, placebo-controlled trial tested Cognigrape at 250 mg capsules on cognitive effects using successive balanced blocks in testing.

Clinical Summary

Randomized controlled trials in healthy older adults have demonstrated Cognigrape's efficacy for cognitive enhancement. A double-blind, placebo-controlled study (PMID: 39335927) showed significant improvements in long-term cognitive function measures. Additional clinical research supports short-term cognitive performance benefits, though the evidence base remains moderate in strength with relatively small sample sizes across studies.

Nutritional Profile

Cognigrape is a patented whole grape extract (Vitis vinifera) standardized from Italian red grapes, delivering a concentrated polyphenol complex. Primary bioactive compounds include total polyphenols at approximately 60-70% by weight, with the key fractions being: oligomeric proanthocyanidins (OPCs) as a dominant constituent, anthocyanins (including malvidin-3-glucoside, cyanidin-3-glucoside, peonidin-3-glucoside) contributing to the characteristic color and neuroprotective activity, and resveratrol in modest concentrations (<1%). Flavonols such as quercetin, kaempferol, and myricetin are present as glycoside conjugates. The extract also contains hydroxycinnamic acids (caffeic acid, p-coumaric acid, ferulic acid) and hydroxybenzoic acids (gallic acid, ellagic acid). At the studied dose of 250 mg per capsule, the extract delivers an estimated 150-175 mg total polyphenols per serving. Macronutrient content is negligible at supplemental doses (trace carbohydrates from grape matrix). Minerals detected in whole grape extracts include potassium, calcium, and magnesium at trace levels. Bioavailability is enhanced by the whole-grape matrix approach, which preserves the synergistic interaction between polyphenol classes; anthocyanins show rapid absorption (Tmax ~1-2 hours) with moderate bioavailability (~5-10% of ingested dose reaching systemic circulation), while OPCs demonstrate slower, more sustained absorption.

Preparation & Dosage

The clinically studied dosage is 250 mg per capsule of Cognigrape powder extract, containing Vitis vinifera fruit extract standardized with maltodextrin (30-40%). No other dosage ranges or forms were specified in available trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Ginkgo biloba, Bacopa monnieri, Lion's Mane, Phosphatidylserine, Omega-3

Safety & Interactions

Cognigrape is generally well-tolerated with minimal reported adverse effects in clinical trials. Potential interactions may occur with anticoagulant medications due to the blood-thinning properties of grape seed compounds. Individuals with bleeding disorders should exercise caution, and pregnant or breastfeeding women should avoid use due to insufficient safety data. No serious contraindications have been established in current research.